Skip to content

Harp music: Effects on heart rate variability, cortisol and activity

Harp music: Effects on heart rate variability, cortisol and activity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN61185493
Enrollment
90
Registered
2007-08-29
Start date
2005-04-01
Completion date
Unknown
Last updated
2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity Neonatal Diseases Prematurity

Interventions

Harp music vs quiet room. The infants allocated to the intervention group had harp music for 45 minutes each day for 3 days.

Sponsors

National Institutes of Health, National Center for Complementary and Alternative Medicine (USA)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Infants hospitalized at Brenner Children's Hospital Neonatal Intensive Care or Intermediate Care UnitsInfants were eligible if they satisfied the following criteria: 1. Born between 25 and 36 weeks gestational age 2. At least 34 weeks gestational age by the time of enrollment 3. Had been medically stable in the intermediate care nursery for at least three days 4. Had passed the neonatal hearing screen 5. Slept in a crib rather than an isolette 6. Took full oral feedings 7. Free of apnea and bradycardia spells 8. Expected to remain in the intermediate nursery for at least seven more days to achieve stable body temperature

Exclusion criteria

Exclusion criteria: 1. Any medical condition known to adversely affect either: 1.1. Central nervous system (e.g. intraventricular hemorrhage of Grade II or higher) 1.2. Cardiac or adrenal function (e.g. major cardiac anomaly) 1.3. Movement (e.g. spasticity, hypotonia, or fractured clavicle) 2. Any ongoing need for stressful or invasive medical procedures or steroid medications

Design outcomes

Primary

MeasureTime frame
1. Salivary cortisol was measured just prior to harp music/quiet/usual care observation period and just after each day 2. HRV was measured during the intervention each day 3. Activity was measured during and after the intervention each day 4. Weight, meausred at baseline (Monday) and 5 days (Friday)

Secondary

MeasureTime frame
Growth, measured as weight gain at 5 days (this trial is 5 days long).

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026